Topics
Glioblastoma | Treatment | Clinical trials | Re-irradiation
Home > Publications > Topics > Glioblastoma > Treatment > Clinical trials > Re-irradiation
Chen ATC, Serante AR, Ayres AS,
Tonaki JO, Moreno RA, Shih H, Gattás GS, Lopez OVM, Reis
Dos Santos de Jesus G, de Carvalho IT, Marotta RC, Marta GN, Feher
O, Neto HS, Ribeiro ISN, da Conceição Vasconcelos
KGM, Figueiredo EG, Weltman E.
Prospective
Randomized Phase 2 Trial of Hypofractionated Stereotactic
Radiotherapy of 25 Gy in 5 fractions compared to 35 Gy in 5
fractions in the Reirradiation of Recurrent Glioblastoma.
Int
J Radiat Oncol Biol Phys.
2024 Jan 15:S0360-3016(24)00026-9. doi:
10.1016/j.ijrobp.2024.01.013. PMID:
38232937. Interventional
study˰
ˍ
Iwamoto FM, Tanguturi SK, Nayak L, Wang TJ, Desai A, Lustig RA,
Bagley S, Wong ET, Hertan LM, McCluskey C, Hayden J, Muzikansky A,
Nakhawa S, Japo J, Bossi CC, Meylan M, Tian Y, Barlow GL,
Speliakos P, Ayoub G, Meredith DM, Ligon KL, Haas-Kogan D, Huang
K, Wucherpfennig KW, Wen PY, Reardon DA.
Re-irradiation
plus pembrolizumab: Phase II study
for recurrent glioblastoma patients.
Clin
Cancer Res. 2024 Nov 8.
doi:
10.1158/1078-0432.CCR-24-1629. PMID:
39513953. Interventional study˰
ˍ